Fifth Circuit Reinstates Mifepristone In-Person Dispensing Requirement NationwideMay 22, 2026Legal NewsThe Fifth Circuit reinstated mifepristone's in-person dispensing requirement nationwide on May 1, accepting Louisiana's Medicaid-cost standing theory before the Supreme Court intervened May 4.
5th Circuit Bans Mifepristone Mail Distribution; Drugmakers Rush to Supreme CourtMay 16, 2026Legal NewsThe Fifth Circuit voided FDA's 2021 mail-dispensing rule for mifepristone, banning telehealth prescribing nationwide. The Supreme Court issued an emergency stay May 14.